Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 StudyYukio Hosomi, Akira Inoue, Satoshi Morita et al.|Journal of Clinical Oncology|2019Cited by 483
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03Satoshi Teramukai, Masanori Fukushima, Masaaki Kawahara et al.|European Journal of Cancer|2009Cited by 342